SCHEMBL1700839

SCHEMBL1700839

CC(C)C(C)C(c1ccc(O)c(O)c1)c1ccc(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.57
TDP1 Q9NUW8 9/20 0.57
MAPT P10636 8/20 0.57
RECQL P46063 7/20 0.57
HSD17B10 Q99714 6/20 0.57
MTOR P42345 5/20 0.57
HIF1A Q16665 5/20 0.57
KMT2A Q03164 5/20 0.57
LMNA P02545 4/20 0.57
ALOX15 P16050 4/20 0.57
TSHR P16473 4/20 0.57
NFKB1 P19838 3/20 0.57
POLB P06746 3/20 0.57
BLM P54132 3/20 0.57
THPO P40225 2/20 0.57
APEX1 P27695 1/20 0.57
ADRB2 P07550 5/20 0.46
PTGS2 P35354 3/20 0.46
OPRK1 P41145 2/20 0.46
SLC6A3 Q01959 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8741777 0.86 TUBB4A (0.53) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL2859477 0.80 TDP1 (0.53) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL10582745 0.79 TDP1 (0.57) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL18479371 0.77 KDM4E (0.61) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL20821160 0.77 KDM4E (0.61) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL8741805 0.77 TSHR (0.46) ALOX15TSHRNFKB1BLMALDH1A1
SCHEMBL3937368 0.77 TDP1 (0.59) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL29362968 0.77 TRPA1 (0.67) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL172232 0.77 TRPA1 (0.67) KDM4ETDP1MAPTRECQLHSD17B10
SCHEMBL29525823 0.77 TDP1 (0.65) KDM4ETDP1MAPTRECQLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1748767-A4 DIARYLALKANES AS POTENT INHIBITORS OF BINUCLEAR ENZYMES UNIGEN PHARMACEUTICALS INC (US) 2008-12-24 EP claimed
EP-1748767-A1 DIARYLALKANES AS POTENT INHIBITORS OF BINUCLEAR ENZYMES Unigen Pharmaceuticals, Inc. (US) 2007-02-07 EP claimed
WO-2005117849-A1 DIARYLALKANES AS POTENT INHIBITORS OF BINUCLEAR ENZYMES UNIGEN PHARMACEUTICALS, INC. (US) 2005-12-15 WO claimed
EP-2584897-A1 RESVERATROL-CONTAINING COMPOSITIONS AND METHODS OF USE Resveratrol Partners, Llc (US) 2013-05-01 EP disclosed
WO-2012006065-A1 RESVERATROL-CONTAINING COMPOSITIONS AND METHODS OF USE RESVERATROL PARTNERS, LLC (US) 2012-01-12 WO disclosed
EP-0297733-A2 Pharmaceutical compositions comprising catecholic butanes BLOCK DRUG COMPANY, INC. (US) 1989-01-04 EP disclosed